$CI (Cigna Corp.)

$CI {{ '2016-07-29T13:39:10+0000' | timeago}} • Webcast

Justin Lake of Wolfe Research asks about capital deployment if the Anthem deal is cancelled. $CI said if the deal fails, looking towards the second half of 2017, the company would have about $5Bil of deployable cash. The balance sheet currently has 27% leverage, with normal business adding 10 points and strategic M&A adding 15 points to the same.

$CI {{ '2017-06-08T17:47:25+0000' | timeago}} • Announcement

$CI and $CVS announced the launch of Cigna Health WorksSM, a new collaboration that aligns Cigna-administered health benefits with CVS Pharmacy and CVS MinuteClinic retail health care services to deliver a consumer-friendly experience for Cigna self-funded employer-sponsored health plans.

$CI {{ '2017-05-05T15:12:24+0000' | timeago}} • Webcast

$CI said that the Medicaid business in Illinois, which company has planned to exit, is running at near breakeven. $CI is not characterizing this business as a major headwind or tailwind in terms of the impact. The individual commercial business is in line with expectations and margins were negative, but still better than last year, $CI said.

$CI {{ '2017-05-05T15:02:51+0000' | timeago}} • Infographic

$CI Cigna Corp. Earnings AlphaGraphics: Q1 2017 highlights

$CI {{ '2017-05-05T14:56:28+0000' | timeago}} • Webcast

Relative to Monday's Delaware chancery court review and decision, $CI said that it will not speculate the outcome or timing on that. Earlier, $CI sued $ANTM to collect the breakup fee and damages after its merger agreement with Anthem got failed.

$CI {{ '2017-05-05T14:40:05+0000' | timeago}} • Webcast

$CI stated that Medicaid is a small business for it and saw an increase in Medicaid MCR in Texas and Illinois towards the end of the last year and elevated a little bit in 1Q17. $CI does not plan to participate in the Illinois Medicaid market beyond the end of this year. The exit of that business is considered in the outlook, the company said.

$ANTM {{ '2017-05-05T14:40:01+0000' | timeago}} • Announcement

$ANTM confirmed that it is filing a petition for a writ of certiorari with the U.S. Supreme Court, seeking review of the U.S. Court of Appeals for the D.C. Circuit’s majority decision regarding the acquisition of $CI.

$CI {{ '2017-05-05T11:15:06+0000' | timeago}} • Announcement

For FY17, $CI sees FY17 consolidated adjusted income from operations at $2.41-2.53Bil, or $9.25 to $9.75 per share. The outlook excludes the impact of additional prior year reserve development and potential effects of any future capital deployment. Total revenue growth is expected at 3-4% for the year

$CI {{ '2017-05-05T11:11:14+0000' | timeago}} • Announcement

Total revenues for $CI improved 5% to $10.4Bil in 1Q17, as the health services organization's net income jumped 15% to $598MM from $519MM a year ago, Earnings rose to $2.30 per share from $2.00 a share, as Cigna ended the quarter with cash and marketable investments of $2.7Bil.

$ANTM {{ '2017-04-26T19:33:21+0000' | timeago}} • Webcast

$ANTM said that the Appeals Court verdict can go in three directions with regards to the pending $CI transaction; a) deny the company's appeal, b) accept, but in part and c) accept its appeal in its entirety. After the court's decision, the company will make the best choice. $ANTM added that it is committed to close the acquisition.

$ANTM {{ '2017-02-15T15:08:47+0000' | timeago}} • Announcement

$ANTM filed a suit seeking a temporary restraining order to enjoin $CI from terminating the merger agreement. This is in response to $CI's wrongful purported termination and lawsuit and ongoing campaign to sabotage the merger and deflect attention from its repeated willful breaches of the merger agreement.

$ANTM {{ '2017-02-15T15:07:17+0000' | timeago}} • Announcement

$ANTM filed a lawsuit in the Delaware Court of Chancery seeking a temporary restraining order to enjoin $CI from terminating, and taking any action contrary to the terms of, the Merger Agreement, specific performance compelling $CI to comply with the Merger Agreement and damages.

$ANTM {{ '2017-02-09T15:15:16+0000' | timeago}} • Announcement

$ANTM commented on the decision by the District Court of Columbia granting the Department of Justice’s request to block $ANTM's proposed acquisition of $CI. $ANTM promptly plans to file a notice of appeal and request an expedited hearing of its appeal to reverse the Court’s decision.

$CI {{ '2017-02-02T19:59:56+0000' | timeago}} • Webcast

For 2017, $CI expects Global Healthcare earnings in the range of approx. $2.035-2.115Bil. Full-year 2017 medical cost trend is expected to be 4.5-5.5%. For Global Supplemental Benefits, $CI expects earnings of $295-315MM reflecting business growth. For Group Disability and Life, earnings are expected to be $200-230MM.

$CI {{ '2017-02-02T19:53:23+0000' | timeago}} • Webcast

In $CI’s Group Disability and Life business, full year 2016 results reflect premium and fee growth of 4% over 2015. Full-year 2016 earnings in the Group business were $125MM with 4Q16 earnings of $69MM.

$CI {{ '2017-02-02T19:49:26+0000' | timeago}} • Webcast

For $CI’s total US Commercial book of business, full-year 2016 medical cost trend was modestly below the low end of the guidance range of 4-5%. Total Government medical care ratio of 85.3% reflects solid performance in the Medicare Advantage business and increased medical costs in the Medicaid business.

$CI {{ '2017-02-02T12:18:10+0000' | timeago}} • Announcement

$CI expects its FY17 con consolidated adjusted income from operations is in the range of $2.35-$2.48 Bil, or $9.00-9.50 per share. $CI's outlook excludes the impact of additional prior year reserve development and potential effects of any future capital deployment.

$CI {{ '2017-02-02T12:14:56+0000' | timeago}} • Announcement

$CI reported a 10% YoY growth in its premiums and fees from Global Supplemental Benefits. This rise reflected continued business growth. the premiums and fees rose 4% YoY in the Group Disability and Life segment. This rise was mainly due to business growth across disability and life products.

$CI {{ '2017-02-02T12:09:37+0000' | timeago}} • Announcement

During 4Q16, $CI's premiums and fees from Global Health Care Segment increased 2% YoY, helped by customer growth, specialty contributions, and rate actions in our Commercial business. This was partially offset by reductions in Medicare Part D and Individual customers.

$CI {{ '2017-02-02T12:07:15+0000' | timeago}} • Announcement

Health insurer $CI reported a 10% drop in its 4Q16 earnings, hurt by transaction costs related to $CI's proposed combination with Anthem. Net income fell to $382MM, or $1.47 per share, compared to $426MM, or $1.64 per share during 4Q15. Revenues was $9.94Bil. Adjusted EPS from operations remained flat at $1.87 per share.

$CI {{ '2016-11-03T18:04:22+0000' | timeago}} • Infographic

$CI Cigna Earnings AlphaGraph: Q3 2016 Highlights

Recent Transcripts

UNH (UnitedHealth Group Incorporated)
Tuesday, July 18 2017 - 12:45pm
ENZ (Enzo Biochem Inc.)
Friday, June 9 2017 - 12:30pm
MCK (McKesson Corporation)
Thursday, May 18 2017 - 9:00pm
MYL (Mylan N.V.)
Wednesday, May 10 2017 - 2:00pm
ACAD (ACADIA Pharmaceuticals Inc.)
Tuesday, May 9 2017 - 9:00pm
AGN (Allergan plc)
Tuesday, May 9 2017 - 12:30pm
CI (Cigna Corp.)
Friday, May 5 2017 - 12:30pm
MOH (Molina Healthcare, Inc.)
Thursday, May 4 2017 - 9:00pm
MET (MetLife, Inc.)
Thursday, May 4 2017 - 12:00pm
ALL (The Allstate Corporation)
Wednesday, May 3 2017 - 1:00pm
HUM (Humana Inc.)
Wednesday, May 3 2017 - 1:00pm
OMI (Owens & Minor Inc.)
Wednesday, May 3 2017 - 12:30pm
WCG (WellCare Health Plans, Inc.)
Wednesday, May 3 2017 - 12:00pm
KTWO (K2M Group Holdings, Inc.)
Tuesday, May 2 2017 - 9:00pm
AET (Aetna Inc.)
Tuesday, May 2 2017 - 12:30pm
CAH (Cardinal Health, Inc.)
Monday, May 1 2017 - 12:30pm
CNO (CNO Financial Group, Inc.)
Thursday, April 27 2017 - 3:00pm
ABBV (AbbVie Inc.)
Thursday, April 27 2017 - 1:00pm
UNM (Unum Group)
Thursday, April 27 2017 - 1:00pm
ANTM (Anthem, Inc.)
Wednesday, April 26 2017 - 12:30pm

AlphaGraphics you may like